Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTERACT5: Deferoxamine and Colchicine for Acute Intracerebral Haemorrhage
ChiCTR2400089146Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Sep 2024
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of deferoxamine and colchicine in intracerebral hemorrhage (ICH) (4 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Utility-weighted mRS score at 6 months and Place of residence at 6 months. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
deferoxaminecolchicine
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on ChiCTR2400089146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089146.